Skip to main content
. 2019 Jun 24;4(3):428–437. doi: 10.1016/j.jacbts.2019.02.005

Figure 2.

Figure 2

Costs (in $ Millions) for Development and Validation of Various Types of Biomarkers

Costs for development and validation of biomarkers by type, as estimated by the U.S. Department of Health and Human Services (17).